Back to Search
Start Over
Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer.
- Source :
- Journal of Nuclear Medicine; Oct2021, Vol. 62 Issue 10, p1-29, 29p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 01615505
- Volume :
- 62
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Nuclear Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 153076145
- Full Text :
- https://doi.org/10.2967/jnumed.121.262542